Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles from the last 30 days matching "May 15"

🔴 BreakingDrug approvalOPENFDAYesterday

FDA Approves BAXFENDY (BAXDROSTAT) — New Treatment Available

The FDA has approved a new drug called BAXFENDY (generic name: baxdrostat) made by AstraZeneca. This approval means the drug is now available for patients to use. The approval was granted on May 15, 2026, after the drug met safety and effectiveness standards.

WHY IT MATTERSThis is the first FDA approval of baxdrostat, but the specific rare disease indication is not detailed in this announcement — patients should check with their doctor or the FDA's full label to confirm if this drug applies to their condition.
💬 Ask your doctor
Drug approvalOPENFDA3 days ago

FDA Approves Unknown drug — New Treatment Available

The FDA has approved a new drug made by Accord BioPharma, but the article doesn't say what disease it treats or what the drug is called. The approval happened on May 15, 2026. Patients and doctors should look for more details about this drug from official FDA sources or the company.

WHY IT MATTERSWithout knowing which rare disease this drug treats, we cannot determine its specific impact on patients — more information from the FDA or Accord BioPharma is needed to assess relevance.
ℹ Good to know

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases